Valuation : Circio Holding ASA

Market Cap 365.8Cr 40Cr 34Cr 32Cr 29Cr 55Cr 3.78TCr 55Cr 381.61Cr 147.49Cr 1.93TCr 149.22Cr 145.98Cr 6.1TCr P/E 2024
0.25x
P/E 2025 -2.65x
Enterprise Value 366.03Cr 40Cr 34Cr 32Cr 29Cr 55Cr 3.78TCr 55Cr 381.84Cr 147.58Cr 1.93TCr 149.31Cr 146.07Cr 6.11TCr EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
86.36%
Yield 2024 *
-
Yield 2025 -
1 day-2.55%
1 week+6.92%
Current month+0.46%
1 month+47.50%
3 months+55.64%
6 months+328.38%
Current year+1,015.12%
1 week 11.7
Extreme 11.7
13.8
1 month 8.34
Extreme 8.34
15.7
Current year 0.98
Extreme 0.978
15.7
1 year 0.58
Extreme 0.584999
15.7
3 years 0.48
Extreme 0.48
15.7
5 years 0.48
Extreme 0.48
236.7
10 years 0.48
Extreme 0.48
1,017
Manager TitleAgeSince
Chief Executive Officer - 20/10/2021
Director of Finance/CFO 58 07/03/2022
Chief Tech/Sci/R&D Officer - 01/01/2022
Director TitleAgeSince
Director/Board Member 79 01/07/2015
Director/Board Member 66 14/09/2015
Chairman 64 29/04/2020
Date Insider Type Main position Quantity % Market Cap. Importance
30/11/21 Exercice

Chief Executive Officer

1,20,000 0.1386%
19/05/21 Buy

Director

21,299 0.0246%
03/12/20 Buy

Chief Technology Officer

10,000 0.0116%
Change 5-day change 1-year change 3-year change Capi.($)
-2.55%+6.92%+2,000.32%+9.54% 40Cr
-0.94%+0.31%+40.04%+103.25% 6.92TCr
-0.07%-3.93%+32.54%+75.96% 6.3TCr
+3.77%+2.19%-12.09%+388.30% 2.73TCr
-0.43%-5.32%-3.72%-16.67% 2.48TCr
-0.93%-1.29%+25.30%+16.70% 2.58TCr
-1.43%-1.89%+21.32%-17.67% 2.01TCr
-4.27%+2.67%+219.02%+362.48% 1.85TCr
-1.43%-1.80%-8.64%+537.09% 1.49TCr
+0.74%-1.14%+51.15%+163.12% 1.43TCr
Average -0.76%+0.70%+236.52%+162.21% 2.78TCr
Weighted average by Cap. -0.44%-0.75%+39.25%+140.93%

Financials

2024 2025
Net sales - -
Net income 5.75Cr 62.49L 53.77L 50.63L 46.13L 86.32L 59Cr 86.66L 6Cr 2.32Cr 30Cr 2.35Cr 2.3Cr 96Cr -4.59Cr -49.87L -42.91L -40.41L -36.82L -68.89L -47Cr -69.16L -4.79Cr -1.85Cr -24Cr -1.87Cr -1.83Cr -77Cr
Net Debt -10L -1L -90.86T -85.56T -77.96T -1L -1Cr -1L -10.14L -4L -51.19L -4L -4L -1.62Cr 22.45L 2L 2L 2L 2L 3L 2.32Cr 3L 23.42L 9L 1.18Cr 9L 9L 3.75Cr
Logo Circio Holding ASA
Circio Holding ASA, formerly Targovax ASA, is a Norway-based company active within the healthcare sector. The Company is engaged in the biotechnology and develops ribonucleic acid (RNA) and immunotherapy medicines. The Company offers circular RNA (circRNA) platform to develop circRNA medicines for cancer, vaccines, protein replacement for genetic disorders and cell therapy. The circVec technology is based on a modular genetic cassette design for efficient biogenesis of multifunctional circRNA from DNA-based vectors that can be deployed for multiple purposes. Circios strategy is to develop circAde cancer medicines in-house and seek partnerships in other therapeutic areas to demonstrate the broad potential of the circVec platform and accelerate circRNA pipeline development. Circio’s second clinical program is an immunotherapy targeting KRAS driver mutations.
Employees
11
Date Price Change Volume
09/26/09 NOK 12.98 -2.55% 29,83,578
08/26/08 NOK 13.32 +0.60% 1,02,94,871
07/26/07 NOK 13.24 +2.32% 85,51,271
04/26/04 NOK 12.94 +6.07% 1,41,53,698
03/26/03 NOK 12.20 +0.49% 1,30,89,208

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TRVX Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!